Certara Products - Phoenix Archives | Page 3 of 6

Announcement

Latest Phoenix PK/PD analysis & modeling platform release prioritizes efficiency, power

June 16, 2025 RADNOR, PA – June 16, 2025 – Certara, Inc. (Nasdaq: CERT), a…

CertaraJune 16, 2025

On-Demand Webinar

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

CertaraJune 11, 2025

Publication

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

The study, published in the Journal of Clinical Pharmacology, evaluates the cardiac safety of fruquintinib,…

CertaraJune 8, 2025

On-Demand Webinar

On-Demand Webinar: Streamlining Population PK Modeling with Phoenix NLME and Pirana

Phoenix NLME offers unparalleled flexibility and power for PK/PD analyses, meeting all scientific and technical…

Danielle PillsburyJune 5, 2025

On-Demand Webinar

Transform Your PK/PD Workflow with AI and the Cloud

Watch our on-demand webinar to see how AI and cloud technology will revolutionize your daily…

Danielle PillsburyJune 5, 2025

Webinar

Accelerate IVIVC Modeling: How Formulation Scientists Can Save Time and Reduce Clinical Study Burden

CertaraJune 5, 2025

On-Demand Webinar

Pharmacokinetic Modeling of Neutralizing ADA Effects in Translational Development

CertaraMay 21, 2025

Blog Knowledge Base

Extrapolating AUC to Infinity

AUC calculations are simple but nuanced. In this blog, we look at how to extrapolate…

CertaraMay 15, 2025

On-Demand Webinar

Explore First: How a Stepwise Approach to QTc Studies Reduces Time, Cost, and Regulatory Risk

Learn how a stepwise C-QTc approach can streamline cardiac safety evaluation, reduce costs, and align…

CertaraMay 5, 2025

On-Demand Webinar

Streamlining Population PK Modeling with Phoenix NLME & Pirana: Bridging Efficiency and Precision in Pharmacometrics [APAC Webinar]

Senior Director, Pharmacometric Software, Certara Keith has more than 20 years of global drug development…

CertaraApril 24, 2025

Certara Products – Phoenix

Latest Phoenix PK/PD analysis & modeling platform release prioritizes efficiency, power

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

Assessment of the Effects of Fruquintinib on Cardiac Safety in Patients with Metastatic Colorectal Cancer

On-Demand Webinar: Streamlining Population PK Modeling with Phoenix NLME and Pirana

Transform Your PK/PD Workflow with AI and the Cloud

Accelerate IVIVC Modeling: How Formulation Scientists Can Save Time and Reduce Clinical Study Burden

Pharmacokinetic Modeling of Neutralizing ADA Effects in Translational Development

Extrapolating AUC to Infinity

Explore First: How a Stepwise Approach to QTc Studies Reduces Time, Cost, and Regulatory Risk

Streamlining Population PK Modeling with Phoenix NLME & Pirana: Bridging Efficiency and Precision in Pharmacometrics [APAC Webinar]

Newsletter sign up

Quick links

Solutions

Contact